MedMesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Cytokine Receptor gp130 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cytochrome P-450 Enzyme System < Cytokine Receptor gp130 < Cytokine Release Syndrome  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000D20 (2016) Xiao Liu [Royaume-Uni] ; Gareth W. Jones ; Ernest H. Choy ; Simon A. JonesThe biology behind interleukin-6 targeted interventions.
001048 (2015) Kazuko Uno [Japon] ; Kazuyuki Yoshizaki [Japon] ; Mitsuhiro Iwahashi [Japon] ; Jiro Yamana [Japon] ; Seizo Yamana [Japon] ; Miki Tanigawa [Japon] ; Katsumi Yagi [Japon]Pretreatment Prediction of Individual Rheumatoid Arthritis Patients' Response to Anti-Cytokine Therapy Using Serum Cytokine/Chemokine/Soluble Receptor Biomarkers.
001498 (2013) M J Kraakman [Australie] ; T L Allen ; M. Whitham ; P. Iliades ; H L Kammoun ; E. Estevez ; G I Lancaster ; M A FebbraioTargeting gp130 to prevent inflammation and promote insulin action.
001764 (2012) Mami Noda [Japon] ; Yukiko Yamakawa ; Naoya Matsunaga ; Satoko Naoe ; Taishi Jodoi ; Megumi Yamafuji ; Nozomi Akimoto ; Norihiro Teramoto ; Kyota Fujita ; Shigehiro Ohdo ; Haruo IguchiIL-6 receptor is a possible target against growth of metastasized lung tumor cells in the brain.
001839 (2011) Simon A. Jones [Royaume-Uni] ; Jürgen Scheller ; Stefan Rose-JohnTherapeutic strategies for the clinical blockade of IL-6/gp130 signaling.
001894 (2011) Christoph Garbers [Allemagne] ; Wolfgang Thaiss ; Gareth W. Jones ; Georg H. Waetzig ; Inken Lorenzen ; Florence Guilhot ; Rami Lissilaa ; Walter G. Ferlin ; Joachim Grötzinger ; Simon A. Jones ; Stefan Rose-John ; Jürgen SchellerInhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.
001A16 (2010) Eric Assier [France] ; Marie-Christophe Boissier ; Jean-Michel DayerInterleukin-6: from identification of the cytokine to development of targeted treatments.
001A22 (2010) Claudia Drucker [Allemagne] ; Jessica Gewiese ; Sven Malchow ; Jürgen Scheller ; Stefan Rose-JohnImpact of interleukin-6 classic- and trans-signaling on liver damage and regeneration.
001A88 (2009) Michael T. Nurmohamed [Pays-Bas]Newer biological agents in the treatment of rheumatoid arthritis: do the benefits outweigh the risks?
001A97 (2009) Shoko Nakajima [Japon] ; Takuya Naruto ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Shigeru Nishimaki ; Shumpei YokotaInterleukin-6 inhibits early differentiation of ATDC5 chondrogenic progenitor cells.
001A99 (2009) Misato Hashizume [Japon] ; Masahiko MiharaInfluence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling.
001B88 (2007) Bruce N. Cronstein [États-Unis]Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Cytokine Receptor gp130" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Cytokine Receptor gp130" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Cytokine Receptor gp130
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021